SCCT & Cleerly are proud to announce the 2024 CTRA winner 🏆 Dr. Chan's ORFAN Study highlights the role of coronary inflammation as a potential therapeutic target in #cardiovascular disease (#CVD) prevention, using #FAIscore from #CCTA. More ➡️ ow.ly/Tha150Skml2

Right Treatment for the Right Patient: Mavacamten Cannot Fix Everythin... sciencedirect.com/science/articl… While mavacamten is very good in symptomatic #oHCM pts, crucial to make the right diagnosis upstream. Leveraging multimodality imaging to optimize diagnosis and downstream mgmt.

Two cardiac myosin inhibitors in the treatment of obstructive hypertro... sciencedirect.com/science/articl… It’s not every day you get the privilege to comment on a dz with a co-author who discovered and described the dz. Eugene Braunwald #oHCM Hypertrophic Cardiomyopathy Medical Society HCMA - Hypertrophic Cardiomyopathy Association Cleveland Clinic Heart, Vascular & Thoracic CCF Cardiology Fellows

This piece from TIME discusses #HCM treatments, including the next frontier of innovation to address #heartdisease: #genetherapy. Read more to hear from Milind Desai MD MBA, Director Cleveland Clinic & investigator for the MyPeak™-1 Phase 1b clinical trial: bit.ly/49D57Nh

Since the 1950s, Cleveland Clinic has been a pioneer in heart care. Ranking #1 for the 30th year shows our sustained commitment to excellence. Congratulations to Cleveland Clinic Heart, Vascular & Thoracic & to all of our caregivers. Your dedication to our patients is inspiring. bit.ly/3WpsxS3

It’s an honor to be recognized as the #1 hospital for heart care for the 30th consecutive year. This is a testament to the commitment, talent and compassion of our Cleveland Clinic Heart, Vascular & Thoracic team. They’re dedicated to excellence in every aspect of their work. newsroom.clevelandclinic.org/2024/07/16/cle…

Which imaging method is the best one to diagnose left ventricular tract obstruction? Find out more on #ESCTVToday 👉 bit.ly/3yuqCDF Sign up for reminders so you Never Miss a Beat bit.ly/3IQ1B7G #CVD Milind Desai MD MBA

🏥For patients with obstructive #HCM, accurate imaging and measurements pre-surgery are vital. A new study by Dr. Milind Desai Milind Desai MD MBA of Cleveland Clinic in American Journal of Cardiology compared the effectiveness of TEE and MRI. Explore his expert insights here: buff.ly/3yWKEqr

Attending #ESCCongress in #London? Join Cleveland Clinic Friday, August 30, 12:30-1:30pm, for a complimentary lunch symposium in the Copenhagen Room. Registration available onsite. Link: url.us.m.mimecastprotect.com/s/-iTuC9rBVviY… Milind Desai MD MBA CCF Cardiology Fellows #ESC2024

Excellent case-based symposium at #ESC2024 from Cleveland Clinic Heart, Vascular & Thoracic. Drs. Leslie Cho, Wael Jaber Milind Desai MD MBA

Long-Term Outcomes of Patients With Apical Hypertrophic Cardiomyopathy Utilizing a New Risk Score | JACC: Advances jacc.org/doi/10.1016/j.… Simultaneous publication with #ESC2024

Apical hypertrophic cardiomyopathy (aHCM) constituted 6.8% of our overall HCM cohort with a composite event rate of 2.8%/year. The aHCM risk score provided good discrimination in predicting the composite primary endpoint, with a higher score associated with a higher rate of

In VALOR-HCM, treatment with mavacamten improved LV-GLS at Week 56, suggesting a favorable long-term impact on regional LV systolic function, without RV dysfunction. Simultaneous pub with #ESCCongress @desaimilindy #AHAJournals ahajournals.org/doi/10.1161/CI…

In VALOR-HCM, mavacamten significantly improved LAVI & LA strain at week 56, suggesting sustained favorable LA remodeling & improved function, except in the AF subgroup. This improvement was assoc w/ meaningful improvement in #QoL. bit.ly/3Z7oNaB #JACCIMG #ESCCongress

Join team #CLEaorta & our fantastic community TheMarfanFoundation’s #Cleveland Walk for Victory on Sat, 9/14 Cleveland Clinic🫀 Register, or consider making a donation, at link: give.marfan.org/event/2024-cle… Cleveland Clinic Heart, Vascular & Thoracic Francis Caputo MD Milind Desai MD MBA SagarKalahastiMD #AortaEd #aorticawareness

We share our latest volumes & outcomes data Cleveland Clinic, in thoracic surgery, lung transplantation, hypertrophic obstructive cardiomyopathy & pericarditis. Kenneth McCurry Milind Desai MD MBA Allan L. Klein Cleveland Clinic CTS Residency CCF Cardiology Fellows consultqd.clevelandclinic.org/vital-statisti…

Magnitude health improvement combined with longevity of the effect may make #mavacamten an equal to surgical myomectomy: Do you agree? 🤔 bit.ly/3XiOKRW #JACC #cvHCM Paul Cremer MD Milind Desai MD MBA

Celebrating one of healthcare’s most remarkable milestones - 30 consecutive years as the #1 heart program🫀 A testament to Cleveland Clinic Heart, Vascular & Thoracic’s incredible work & dedication to the patients we serve. We will continue to strive to be the best, with our vision bright for the future!

Newsweek has named Cleveland Clinic the world’s #1 smart hospital, and one of the world’s top hospitals for specialized care, including #1 in urology. Technological advances are key to inventing tomorrow’s care and will help us reach more patients. bit.ly/47rRRMd

Serial strain assessments show sustained favorable impacts on LV systolic function & LA function - so conclude two subanalyses of the pivotal phase 3 VALOR-HCM study of mavacamten through 56 weeks. Milind Desai MD MBA CCF Cardiology Fellows consultqd.clevelandclinic.org/mavacamtens-ef…